Aarkstore.com 10% Discount || Rx-to-OTC Switching Strategies - New Switching Opportunities ||

							Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Rx-to-OTC Switching Strategies - New Switching Opportunities
in Weight Management and Smoking Cessation, but
Encouraging the Uptake of Self-Medication Remains a
Challenge


http://www.aarkstore.com/reports/Rx-to-OTC-Switching-Strategies-New-
Switching-Opportunities-in-Weight-Management-and-Smoking-Cessation-but-
Encouraging-the-Uptake-of-Self-Medication-Remains-a-Challenge-
200530.html




Summary

GBI Research, a leading business intelligence provider, has released its latest
research “Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight
Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication
Remains a Challenge” examines the key issues influencing the global OTC market
and assesses why companies switch Rx drugs to OTC, their business strategies and
the potential challenges and opportunities this creates. It provides an analysis of the
global OTC market and forecasts broken down by geography and therapy areas. It
discusses the national and international factors which impact the OTC market and
companies operating in the OTC market. The report reviews the regulatory
landscape in the US, Europe and Japan and highlights recent changes in regulatory
procedures and guidelines. Therapy profiles provide a detailed analysis of the
leading OTC drug classes and Company profiles provide a detailed analysis of the
leading OTC companies. Finally the report discusses the challenges and future
opportunities in the OTC market, business strategies and future outlook.

Scope

- Data and analysis on the Rx-to-OTC switch market in the top seven countries which
includes the US, the UK, France, Germany, Spain, Italy and Japan,
- Market Data on geographical landscape including country wise revenues, market
size and market share.
- Key drivers and restraints that have created significant impact on the market.
- Regulatory landscape including the product approval process and overview of
regulatory authorities in the top seven countries.

Table of contents:

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Defines an OTC Product? 8
2.2 Why do Companies Switch Rx Products OTC? 8
2.3 Which OTC Products are Currently Available? 8
2.4 What Geographical Markets Attract OTC Switching? 10
2.5 What Are the Potential New Areas For OTC Drug Development and Why? 12
2.6 GBI Research Report Guidance 13
3 Market Characterization and Forecasts 14
3.1 Global OTC Market by Revenues 14
3.2 Global OTC Market by Region 15
3.3 Global OTC Market - Key Players 16
3.4 Global OTC Market by Therapy 17
3.5 The European OTC Market 18
3.5.1 France 20
3.5.2 Germany 20
3.5.3 Italy 21
3.5.4 The UK 21
3.5.5 Other European Countries 22
3.5.6 European OTC Market Forecasts 23
3.6 Japanese OTC Market 24
3.6.1 Japanese OTC Market Forecasts 25
3.7 North American OTC Market 26
3.7.1 The US 27
3.7.2 Canada 28
3.7.3 Latin American Countries 28
3.7.4 North America OTC Market Forecasts 29
3.8 Trends and Conclusions 30
4 Market Drivers and Restraints 31
5 Growing and Aging Populations 32
5.1 Emerging Consumer 34
5.2 Consumer Empowerment and Education 35

List of Figures

List of Tables are also include.




For more DISCOUNT related Reports Plz follow The link:



Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations,
Regulatory Approvals and Increasing Disease Prevalence Present Growth
Opportunities

Cardiac Assist Device Market to 2017 – Increasing Uptake of Ventricular Assist
Devices and Total Artificial Heart to Drive Growth

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and
Biosimilars to Drive Revenues

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight
Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication
Remains a Challenge

Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines
and Echinocandins to Slow Value Growth



Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1



Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain
Innovation with Low Risk and High Value Offerings

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and
Biosimilars to Drive Revenues

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight
Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication
Remains a Challenge

Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles,
Allylamines and Echinocandins to Slow Value Growth




You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com